Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Si Nafa Si Ahmed

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Anti-Infective Therapy|April 7, 2009
Pathobiology of HBV mutants and clinical impact for treatment monitoringSi Nafa Si Ahmed, Fabien Zoulim
Expert Review of Gastroenterology & Hepatology|February 9, 2010
End points of therapy in chronic hepatitis BSi Nafa Si Ahmed, Marie Ecochard, Fabien Zoulim
Expert Review of Anti-Infective Therapy|April 10, 2010
Management of nonresponsive hepatitis CFrançois Bailly, Si Nafa Si Ahmed, Pierre Pradat, et al.
Gastroenterologie Clinique Et Biologique|March 2, 2005
Disposal of injection material used for the treatment of hepatitis C: comparison with insulin-dependent diabetes and thromboembolismXavier Causse, Louis D'Alteroche, Si Nafa Si Ahmed, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Journal of Hepatology|January 24, 2006
Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)Marianne Maynard, Pierre Pradat, François Bailly, et al.
European Journal of Gastroenterology & Hepatology|September 13, 2013
Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis BJoseph Koffi, Romance Egounlety, Pierre Pradat, et al.
Gastroenterologie Clinique Et Biologique|March 30, 2005
Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study)Xavier Causse, Si Nafa Si Ahmed, Jacques Gros, et al.
The Journal of General Virology|November 1, 2015
FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potentialJessica Cottarel, Marie-Laure Plissonnier, Majlinda Kullolli, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Anti-Infective Therapy|April 7, 2009
Pathobiology of HBV mutants and clinical impact for treatment monitoringSi Nafa Si Ahmed, Fabien Zoulim
Expert Review of Gastroenterology & Hepatology|February 9, 2010
End points of therapy in chronic hepatitis BSi Nafa Si Ahmed, Marie Ecochard, Fabien Zoulim
Expert Review of Anti-Infective Therapy|April 10, 2010
Management of nonresponsive hepatitis CFrançois Bailly, Si Nafa Si Ahmed, Pierre Pradat, et al.
Gastroenterologie Clinique Et Biologique|March 2, 2005
Disposal of injection material used for the treatment of hepatitis C: comparison with insulin-dependent diabetes and thromboembolismXavier Causse, Louis D'Alteroche, Si Nafa Si Ahmed, et al.
Annals of Hepatology|June 6, 2019
Hepatitis C virus infection impacts work productivity and fatigue: An epidemiologic real-life studyVictor de Ledinghen, Bertrand Hanslik, Joseph Moussalli, et al.
Journal of Hepatology|January 24, 2006
Amantadine triple therapy for non-responder hepatitis C patients. Clues for controversies (ANRS HC 03 BITRI)Marianne Maynard, Pierre Pradat, François Bailly, et al.
European Journal of Gastroenterology & Hepatology|September 13, 2013
Impact of lamivudine-resistance mutations on entecavir treatment outcome in hepatitis BJoseph Koffi, Romance Egounlety, Pierre Pradat, et al.
Gastroenterologie Clinique Et Biologique|March 30, 2005
Treatment of chronic hepatitis C in patients unresponsive to interferon. Interest of re-treatment combining interferon induction therapy and ribavirin (a multicenter pilot study)Xavier Causse, Si Nafa Si Ahmed, Jacques Gros, et al.
The Journal of General Virology|November 1, 2015
FIG4 is a hepatitis C virus particle-bound protein implicated in virion morphogenesis and infectivity with cholesteryl ester modulation potentialJessica Cottarel, Marie-Laure Plissonnier, Majlinda Kullolli, et al.
Antiviral Research|July 20, 2011
Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter studySi-Nafa Si-Ahmed, Pierre Pradat, Roeland Zoutendijk, et al.
Pageof 2